Leonurine

Academician Zhu Yi Zhun’s Research Team -Leonurine

 Jointly developed by the research team of Chair Prof. Yizhun Zhu of M.U.S.T. academia Scientiarum et Artium Europaea and Fudan University, Leonurine proves to have fast and significant effect on treatment of acute strokes, thus becoming a major blessing for mid- and old-age cardiovascular disease patients. Zhongzhu Healthcare bought the IP of the project at 150 million Yuan, and the drug has now entered clinical research in China (Phase II on-going) and in the USA.

The left and right figures respectively depict the finished product diagram of Chair Professor Zhu Yizhun’s research on andrographolide. The below figure shows Chair Professor Zhu Yizhun receiving an invention award certificate in Geneva.